|
|
| | 1H-Pyrido[4,3-b]indol-1-one, 2,5-dihydro-5-(5-hydroxypentyl)-2-(1-methyl-1-phenylethyl)- Basic information |
| | 1H-Pyrido[4,3-b]indol-1-one, 2,5-dihydro-5-(5-hydroxypentyl)-2-(1-methyl-1-phenylethyl)- Chemical Properties |
| Boiling point | 613.1±55.0 °C(Predicted) | | density | 1.14±0.1 g/cm3(Predicted) | | solubility | DMF: 10 mg/ml; DMSO: 10 mg/ml; DMSO:PBS (pH 7.2) (1:2): 0.5 mg/ml; Ethanol: 5 mg/ml | | form | A crystalline solid | | pka | 15.17±0.10(Predicted) |
| | 1H-Pyrido[4,3-b]indol-1-one, 2,5-dihydro-5-(5-hydroxypentyl)-2-(1-methyl-1-phenylethyl)- Usage And Synthesis |
| Description | 5-fluoro CUMYL-PeGACLONE N-(5-hydroxypentyl) metabolite is an analytical reference standard categorized as a synthetic cannabinoid metabolite.1 5-fluoro CUMYL-PeGACLONE N-(5-hydroxypentyl) metabolite is a metabolite of 5-fluoro CUMYL-PeGACLONE . This product is intended for research and forensic applications. | | References | 1. Mogler, L., Halter, S., Wilde, M., et al. Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE Forensic Toxicol. 37(1),154-163(2019). |
| | 1H-Pyrido[4,3-b]indol-1-one, 2,5-dihydro-5-(5-hydroxypentyl)-2-(1-methyl-1-phenylethyl)- Preparation Products And Raw materials |
|